Was Hims & Hers' "Free Consultation" Really a Medical Visit? Why the FTC Lawsuit Matters

<p>The provided documents discuss a <strong>2026 legal action</strong> taken by the <strong>Federal Trade Commission (FTC)</strong> against the telehealth company <strong>Hims &amp; Hers</strong>. The primary allegations involve <strong>deceptive billing practices</strong>, where users were charged for subscriptions before receiving a medical review, and the <strong>unauthorized sharing of sensitive health data</strong> with social media advertising platforms. While the company&#39;s <strong>asynchronous consultation model</strong> is common in the United States, the FTC argues that the specific <strong>sequence of payment and consent</strong> misled consumers. The text contrasts these American practices with <strong>Japanese medical regulations</strong>, which strictly require <strong>real-time interaction</strong> for a valid diagnosis. Ultimately, the source suggests this lawsuit will force telehealth providers to adopt <strong>more transparent consent steps</strong> and stronger <strong>data privacy protections</strong> to avoid regulatory penalties.</p>